These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 10053228)
21. Splicing mutation of presenilin-1 gene for early-onset familial Alzheimer's disease. Sato S; Kamino K; Miki T; Doi A; Ii K; St George-Hyslop PH; Ogihara T; Sakaki Y Hum Mutat; 1998; Suppl 1():S91-4. PubMed ID: 9452052 [No Abstract] [Full Text] [Related]
22. Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease. Sodeyama N; Itoh Y; Suematsu N; Matsushita M; Otomo E; Mizusawa H; Yamada M J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):548-51. PubMed ID: 9576554 [TBL] [Abstract][Full Text] [Related]
23. [Recent progress in 'HMGA1a' which causes aberrant splicing of Presenilin-2 pre-mRNA in sporadic Alzheimer's disease]. Katayama T; Manabe T; Tohyama M Nihon Rinsho; 2003 Apr; 61(4):677-88. PubMed ID: 12718095 [TBL] [Abstract][Full Text] [Related]
24. Alzheimer's presenilin 1 gene expression in platelets and megakaryocytes. Identification of a novel splice variant. Vidal R; Ghiso J; Wisniewski T; Frangione B FEBS Lett; 1996 Sep; 393(1):19-23. PubMed ID: 8804415 [TBL] [Abstract][Full Text] [Related]
25. Presenilin function in APP processing. Annaert W; Cupers P; Saftig P; De Strooper B Ann N Y Acad Sci; 2000; 920():158-64. PubMed ID: 11193144 [TBL] [Abstract][Full Text] [Related]
26. The cytosolic inclusion bodies that consist of splice variants that lack exon 5 of the presenilin-2 gene differ obviously from Hirano bodies observed in the brain from sporadic cases of Alzheimer's disease patients. Manabe T; Katayama T; Sato N; Kudo T; Matsuzaki S; Imaizumi K; Tohyama M Neurosci Lett; 2002 Aug; 328(2):198-200. PubMed ID: 12133587 [TBL] [Abstract][Full Text] [Related]
27. Alternative transcripts of presenilin-1 associated with frontotemporal dementia. Evin G; Smith MJ; Tziotis A; McLean C; Canterford L; Sharples RA; Cappai R; Weidemann A; Beyreuther K; Cotton RG; Masters CL; Culvenor JG Neuroreport; 2002 Apr; 13(5):719-23. PubMed ID: 11973477 [TBL] [Abstract][Full Text] [Related]
28. Novel intronic polymorphisms in the presenilin-2 gene and a case-control association study of Alzheimer's disease. Honda M; Kaname T; Igata-Yi R; Igata T; Hitoshi Y; Ogomori K; Miyakawa T; Yamamura KI Psychiatry Clin Neurosci; 1999 Oct; 53(5):579-85. PubMed ID: 10595683 [TBL] [Abstract][Full Text] [Related]
29. Presenilin 2 mutation does not influence expression and concentration of APP forms in human platelets. Pastorino L; Colciaghi F; Marcon G; Borroni B; Cottini E; Cattabeni F; Padovani A; Di Luca M Mol Med; 2000 Oct; 6(10):816-24. PubMed ID: 11126197 [TBL] [Abstract][Full Text] [Related]
30. Assignment of Alzheimer's presenilin-1 (PS-1) gene to 14q24.3 by fluorescence in situ hybridization. Takano T; Yamanouchi Y; Sahara N; Shirasawa T; Mori H Neurosci Lett; 1996 Aug; 214(1):69-71. PubMed ID: 8873134 [TBL] [Abstract][Full Text] [Related]
31. Alternative transcripts of presenilin-1 associated with frontotemporal dementia. Evin G; Smith MJ; Tziotis A; McLean C; Canterford L; Sharples RA; Cappai R; Weidemann A; Beyreuther K; Cotton RG; Masters CL; Culvenor JG Neuroreport; 2002 May; 13(6):917-21. PubMed ID: 11997713 [TBL] [Abstract][Full Text] [Related]
32. Immunoreactivity of presenilin-1 and tau in Alzheimer's disease brain. Hendriks L; De Jonghe C; Lübke U; Woodrow S; Vanderhoeven I; Boons J; Cras P; Martin JJ; Van Broeckhoven C Exp Neurol; 1998 Feb; 149(2):341-8. PubMed ID: 9500965 [TBL] [Abstract][Full Text] [Related]
33. [Mutation site of presenilin-1 gene in familial Alzheimer's disease]. Xu E; Jia J; Sun W Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1518-20. PubMed ID: 12609057 [TBL] [Abstract][Full Text] [Related]
34. Missense mutations in the chromosome 14 familial Alzheimer's disease presenilin 1 gene. Poorkaj P; Sharma V; Anderson L; Nemens E; Alonso ME; Orr H; White J; Heston L; Bird TD; Schellenberg GD Hum Mutat; 1998; 11(3):216-21. PubMed ID: 9521423 [TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical analysis of presenilin-1 expression in the mouse brain. Moussaoui S; Czech C; Pradier L; Blanchard V; Bonici B; Gohin M; Imperato A; Revah F FEBS Lett; 1996 Apr; 383(3):219-22. PubMed ID: 8925899 [TBL] [Abstract][Full Text] [Related]
37. High concentrations of PS-1 mRNA in skin fibroblasts of patients with Down's syndrome. Ikeda K; Urakami K; Isoe K; Nakashima K; Ohno K J Neurol Neurosurg Psychiatry; 1998 May; 64(5):690-1. PubMed ID: 9598700 [No Abstract] [Full Text] [Related]
38. Increased A beta 42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene. Ishii K; Ii K; Hasegawa T; Shoji S; Doi A; Mori H Neurosci Lett; 1997 May; 228(1):17-20. PubMed ID: 9197277 [TBL] [Abstract][Full Text] [Related]
39. A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex. Garzon D; Yu G; Fahnestock M J Neurochem; 2002 Sep; 82(5):1058-64. PubMed ID: 12358753 [TBL] [Abstract][Full Text] [Related]